Pharmacokinetic monitoring of high-dose methotrexate. Early recognition of high-risk patients

Cancer Chemother Pharmacol. 1979;3(3):161-6. doi: 10.1007/BF00262416.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Bone Neoplasms / drug therapy
  • Drug Therapy, Combination
  • Half-Life
  • Humans
  • Kinetics
  • Leucovorin / therapeutic use
  • Methotrexate / administration & dosage
  • Methotrexate / adverse effects
  • Methotrexate / metabolism*
  • Methotrexate / therapeutic use
  • Osteosarcoma / drug therapy
  • Risk
  • Time Factors

Substances

  • Leucovorin
  • Methotrexate